• Client Login
Ozmosi
  • Services
    • BEAM Clinical Trial Data
    • GCT Global Clinical Trials
    • PRYZM Pharma Product Database
    • PDUFA Calendar
    • KRYSTL Industry Scan Reporting
    • LENZ Company Pipeline Summary
    • Specialized Consulting
    • Approved Pharmaceutical Products in Use
  • About Us
  • Case Studies
  • Newsroom
  • Contact Us
Select Page
Who’s Winning the Pharmaceutical R&D Pipeline Race in 2025

Who’s Winning the Pharmaceutical R&D Pipeline Race in 2025

Sep 11, 2025 | Business, Data Analytics, Industry Trends, Market Scan, New Technology, Probability of Success

The leaders, the contenders, and the strategies for success As we approach the 4th quarter of 2025, let’s review where the pharmaceutical industry’s leading companies rank in terms of overall pipeline strength. Roche, AstraZeneca, and Bristol-Myers Squibb sit in a...
Merck Diabetes Pipeline Analysis

Merck Diabetes Pipeline Analysis

Aug 25, 2025 | Business, Data Analytics, Diabetes, Disease Area Trends

Merck’s two blockbuster diabetes products, Janumet® and Januvia®, are DPP-4 inhibitors that generated nearly $3.3 billion in Sales in 2016.3 Januvia® is especially known for its great cardiovascular safety profile, which has helped differentiate itself in its class....

Recent Posts

  • How Next-Generation Probability of Success Forecasting Can Improve Clinical Trial Accuracy by 44%September 15, 2025
  • Market Overview: GLP-1 Agonists and the Obesity MarketSeptember 15, 2025
  • Who’s Winning the Pharmaceutical R&D Pipeline Race in 2025September 11, 2025
  • Not Your Grandparents’ Probability of Success ForecastsSeptember 8, 2025
  • Clinical Trial Success Rates: What Makes Some Companies Stand Out?September 8, 2025
  • Uncovering New Catalyst Events in the Pharmaceutical and Biotech MarketsAugust 28, 2025
  • Home
  • About Us
  • Services
  • Case Studies
  • Newsroom
  • Contact Us
  • Facebook
  • X
OZMOSI© 2025 | All Rights Reserved | Site by Webtyde